Trade Mark Journal No.2026/041 9 October 2026

WO0000001938922 (1,5,9,42)

Office of origin: European Union Intellectual Property Office (EUIPO)

Date of International Registration:5 August 2026
Date of designation in the UK: 5 August 2026
Image for mark 1938922_TIF FABfinity

International priority date claimed: 9 February 2026 (European Union Intellectual Property Office (EUIPO)) (019314726)
Class 1
Chemical and biochemical preparations for use in research and laboratories, in particular reagents for pharmacological research, chemical reagents for chromatographic immobilization, purification or isolation of biological materials; chemical reagents for chromatographic immobilization, purification or isolation of cells, in particular body cells, stem cells and cells of the immune system of mammals including human cells; affinity chromatography reagents used in columns for immobilization, purification or isolation of cells, in particular for immobilization or purification of body cells, stem cells, and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes.
Class 5
Pharmaceutical preparations, in particular cells, in particular body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; body cells, stem cells and cells of the immune systems for treatment of cancerous diseases, autoimmune diseases, viral infections or bacterial infections, genetically modified human immune cells, including T-cells, B-cells, natural killer cells and monocytes, for treatment of cancerous diseases, autoimmune diseases, viral infections or bacterial infections, in vivo diagnostic reagents for medical purposes.
Class 9
Scientific apparatus for the chromatographic immobilization, purification or isolation of biological materials; chromatography columns; scientific apparatus for the chromatographic immobilization, purification or isolations of cells, in particular body cells, stem cells, and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes.
Class 42
Scientific services and research relating thereto in the fields of biology, chemistry, medicine, immunology, oncology, molecular biology, cellular biology, biochemistry and/or medicinal chemistry as well as in the fields of discovery and development of pharmaceuticals, medical preparations, in particular cellular therapy products, including body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes, diagnostic preparations and biomarker reagents and/or diagnostic apparatus.

TQ Therapeutics GmbH

Representative: SCHIWECK WEINZIERL KOCH PATENTANWÄLTE PARTNERSCHAFT MBB, Ganghoferstrasse 68b, 80339 München, GERMANY